McKesson Corporation (MCK)

NYSE - Nasdaq Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

202.59+1.79 (+0.89%)

At close: 4:03PM EDT

201.87 -0.72 (-0.36%)
After hours: 04:47PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	200.80
Open	202.21
Bid	199.27 x 800
Ask	202.60 x 800
Day's Range	201.59 - 203.73
52 Week Range	141.32 - 210.00
Volume	356,863
Avg. Volume	887,206

Market Cap	31.336B
Beta (5Y Monthly)	0.85
PE Ratio (TTM)	N/A
EPS (TTM)	-28.26
Earnings Date	Nov 01, 2021
Forward Dividend & Yield	1.88 (0.93%)
Ex-Dividend Date	Aug 31, 2021
1y Target Est	240.31

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

27% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for MCK

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

McKesson Corporation
Analyst Report: McKesson CorporationMcKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. Outside the U.S. market, McKesson engages in pharmaceutical wholesale and distribution in Europe and Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Rating
Fair Value
Economic Moat
last monthMorningstar

All

News

Press Releases

Research Reports

Zacks
Hill-Rom (HRC) New LT Strategy Aids, Y/Y Comparisons Ail
Hill-Rom's (HRC) newly initiated long-term growth strategies through fiscal 2022, focusing on all four strategic priorities, look attractive at this moment.
Zacks
Haemonetics (HAE) Rides on Plasma Arm Recovery Amid COVID Woes
Haemonetics' (HAE) hospital business is recovering primarily driven by continued improvement in hospital procedures.
Zacks
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now
Investors are optimistic about Thermo Fisher (TMO) on strength in end markets and raised 2021 guidance.